Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

HEalth Advocate for Liver Transplant - Pilot

NCT ID: NCT05700799Sponsor: University of California, San FranciscoLast updated: 2025-08-17

Summary

The Health Advocate for Liver Transplant (HEAL-Tx) Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for pediatric liver transplant patients and measure acceptability and feasibility according to RE-AIM.

Arms & interventions

  • BehavioralHealth Advocate

    The Health Advocate intervention will include helping pediatric liver transplant recipients and their families address unmet household social needs (e.g., food insecurity), improve patient-provider communication, and enhance care coordination.

Outcome measures

Primary

  • Changes in caregiver experience

    The investigators will administer a survey of caregiver experiences at study enrollment and at the end of the intervention to assess for changes in caregiver experience with the transplant team. These questions will focus on experiences receiving transplant care, experiences discussing social needs with the transplant team, and overall caregiver subjective assessment of the transplant recipient's overall health.

    Time frame: Baseline and 90 days

Secondary

  • Change in medication adherence using MLVI

    Time frame: Baseline, 90 days, and 180 days

  • The quality of health advocate interactions with the participants, healthcare team, and community-based resources.

    Time frame: 90 days

  • A qualitative assessment of caregiver and healthcare provider satisfaction with the Health Advocate intervention.

    Time frame: 90 days

Eligibility criteria

Sex: AllAge: Up to 17 YearsHealthy volunteers: No
Inclusion Criteria: 1. Patients under 18 years if age that have undergone liver transplantation. 2. Subject and/or parent/legal guardian can provide written informed consent and willing to comply with study procedures. 3. Subject and/or parent/ legal guardian is willing to be contacted in the future by study staff. 4. Patient and/or caregiver felt to be a good fit for this pilot by transplant team. Exclusion Criteria: * Caregiver unwilling or unable to complete the survey. * Child is a ward of the state (e.g. foster care) since present circumstances may not be reflective of child's past or future circumstances. * Non-English, non-Spanish speakers. * Non-US residents. * Greater than 18 years of age at the time of enrollment.

Study locations (1)

University of California San Francisco

San Francisco, California, 94158

Recruiting
Emily Stekol · Contact
415-502-3190emily.stekol@ucsf.edu
Sharad Wadhwani, MD, MPH · Principal Investigator
HEalth Advocate for Liver Transplant - Pilot | Cancerify